11:00:00 AM - 12:15:00 PM ET - The Provider Response to Covid-19

View Session

Overview

---

Providers have been impacted greatly by Covid-19, and their future response will impact health-related actuarial pricing and modeling. We will cover the following topics: • Review the current state on how Covid-19 is impacting provider financials by assembling and discussing the latest articles and topics specific to the provider community. This will include a brief overview of the CARES Act provider relief fund. • Explore various pricing pressures such as lost revenue due to Covid-19, volume shifts from private to public payers and lower utilization due to likely future changes in patient patterns (eg. telemedicine). This will also include the new hospital price transparency legislation and the potential pricing pressure from this. • Assess potential impacts on value-based programs, such as CMS Pathways to Success and Direct Contracting, including increased future interest in capitation models.

Speakers

---

Presenters: Bela Gorman, FSA, MAAA, Josh Reinstein, FSA, MAAA, Timothy Smith, ASA, MAAA
Moderator:

1:00:00 PM - 2:15:00 PM ET - Bundled Payments: Is the Effort Worth the Reward?

View Session

Overview

---

Bundled payments have exploded in popularity over the past several years, with thousands of providers nationwide participating in Medicare, Medicaid,and commercial bundled payment arrangements. These alternative payment arrangements can offer potential rewards to both payers and providers, but they also require substantial investment and aren’t without their own risks. In this session, we will examine the potential opportunities that bundled payments offer both payers and providers, as well as critically examine the costs associated with developing and implementing these types of arrangements. We will use case studies that include commercial payer representatives, provider representatives and an analytic perspective from Milliman's own experience. At the conclusion of this session, attendees will be able to: • Describe what a bundled payment arrangement is • Evaluate the potential effectiveness of a bundled payment arrangement in various situations • Compare key parameters of various bundled payment arrangements to determine potential opportunity for their organization

Speakers

---

Presenters: Pamela Pelizzari, Andrew J. Madison, ASA, Erin Smith
Moderator:

3:00:00 PM - 4:15:00 PM ET - Transformative Provider Payment Models

View Session

Overview

---

This session will discuss several transformative provider payment models. These include a variety of Value-Based Risk Arrangements redefining the relationship between provider and payer. With these arrangements, the providers are moved from a fee-for-service payment model to one that focuses on reducing the total cost of care. These arrangements also include mechanisms to ensure quality does not suffer. Through data analytics, providers look for innovative ways to reduce unnecessary utilization while optimizing the most effective clinical practices. The presentation will include examples of case studies where these techniques have been established. One case study will highlight what Geisinger has done through their integrated delivery system with primary care redesign,which moves unnecessary care out of the emergency room and back to the primary care setting. We will demonstrate how to reduce the overall cost of care by driving care to the right setting, at the right time and at the right cost (similar to the triple aim). To help keep the session engaging, we will use polling to survey the audience's understanding and experience with value-based models at the beginning and the end of the session. At the conclusion of this session, attendees will be able to: • Define a value-based arrangement • Demonstrate their understanding by identifying examples • Design their own value-based arrangements for their own organization • Describe challenges and preferred outcomes of these arrangements • Create their own models supporting data analytics

Speakers

---

Presenters: Cory Gusland, FSA, MAAA, Sarah MacDerment, FSA, MAAA, Karena Weikel, ASA, MAAA
Moderator:

11:00:00 AM - 12:15:00 PM ET - Supplemental Benefits: Risks and Rewards for Diversification of your MA or Commercial Business

View Session

Overview

---

Supplemental benefits are increasing in popularity and are often being offered alongside traditional major medical insurance in the worksite space or sold alongside Medicare Advantage plans., Our experts will provide a high level overview of these markets and will discuss the risks and rewards of these pairings. At the conclusion of this session, attendees will understand the potential risks and rewards of diversifying their business offering with supplemental health products.

Speakers

---

Presenters: Ashlee Borcan, FSA, MAAA, Milliman, Randall Fitzpatrick, FSA, MAAA
Moderator:

1:00:00 PM - 2:15:00 PM ET - Supplemental Product Trends for 2020 & Beyond

View Session

Overview

---

Supplemental health products have proved to be a significant growth opportunity for carriers over the past decade with consistent year over year growth in new sales and market penetration. Our leadership panel will explore and discuss some of the more recent trends in supplemental product design across a variety of markets and target consumer segments, as well as emerging pricing and risk management challenges which may continue to have an impact on the foreseeable future. Topics for discussion shall include: • Enrollment technology demands and the financial impact of technology costs on expenses • The evolving distribution landscape and the impact on commissions and persistency • Emerging product features, market trends and underwriting practices in the competitive marketplace • Valuation considerations and the impact on in-force management At the conclusion of this session, attendees will be able to: • Describe emerging opportunities and challenges in the supplemental benefits market • Explain how technology and distribution affect product design and pricing for supplemental benefits • Evaluate the advantages and disadvantages of various product and in-force management strategies for supplemental benefits

Speakers

---

Presenters: Randall Finn, FSA, MAAA Sanja Zehnder, FSA, MAAA Mike Prendes, FSA, MAAA
Moderator: Mike Prendes, FSA, MAAA

3:00:00 PM - 4:15:00 PM ET - Supplemental Benefits: Policy Administration can make or break you

View Session

Overview

---

Administration of supplemental benefits is key to successful servicing and difficulties in this area can cost you business. In this session, our experts will discuss key capabilities in administration and contributors to success. At the conclusion of this session, attendees will be able to understand the process involved in administering supplemental health coverage.

Speakers

---

Presenters: Jennifer Howard, FSA, MAAA, Alex Terry, FSA, MAAA, Garrett Viggers, Limelight, Co-founder, Dan Watt, Vice President, Product Management, FINEOS
Moderator: Jennifer Howard

11:00:00 AM - 12:15:00 PM ET - Initiative 18|11 - Managed Care 3.0 Case Studies

View Session

Overview

---

This session will take a look at specific examples of innovation in the health care industry that has reduced cost and improved quality. At the conclusion of this session, attendees will be able to: • Identify risks in the examples • Understand why the solutions were appropriate • How they might be incorporated in their own work.

Speakers

---

Presenters: Melissa Chacko, FSA, MAA, EA, FCA, Elaine Corrough, FSA, MAAA, EA, Roy Goldman, FSA, MAAA, CERA, Wendy Kwan, FSA, MAAA, Michael Pacolay, FSA, MAAA, Karen Shelton, FSA, MAAA, Sara Teppema, FSA, MAAA, FCA
Moderator: Karen Shelton

1:00:00 PM - 2:15:00 PM ET - Actuarial Innovation and Technology - Update on Recent Research

View Session

Overview

---

We will highlight some recent research papers published by the Actuarial Innovation and Technology Committee, including white papers on electronic health records, and epigenetics and underwriting. Participants will learn about some of the the latest innovations in actuarial work and get a preview of future research that the committee is planning.

Speakers

---

Presenters: Brian Chen, Jenna Fariss, ASA, MAAA, James Timmins
Moderator: Mervyn Kopinsky, FSA, EA, MAAA

3:00:00 PM - 4:15:00 PM ET - New Health Plan Innovators

View Session

Overview

---

As medical and group carriers look to gain a competitive edge in the growing supplemental benefits marketplace, we’ll explore specific methods and approaches that carriers are exploring to redefine both the consumer experience and the positioning of these plans within broader group benefits strategies. Speakers will discuss areas of interest, capabilities, challenges, and lessons learned in the way of re-vamping their Accident, Critical Illness, and Hospital Indemnity products for the benefits experience of the future.

Speakers

---

Presenters: Mike Prendes, FSA, MAAA
Moderator:

11:00:00 AM - 12:15:00 PM ET - Understanding and Managing Pharmacy PMPM Risk Through the Use of AMCP Dossiers and Value Frameworks

View Session

Overview

---

A significant number of drug approvals have occurred in the past few years. The availability of new drugs at increasing prices have increased pharmacy PMPM cost risk. There are two useful tools that can help stakeholders plan for and manage this increased risk: the Academy of Managed Care (AMCP) Format for Formulary Submissions (known as the AMCP Dossier) and value frameworks. The intent of this session is to improve actuaries' understanding of valuable information contained in the AMCP Dossier and introduce relevant value frameworks and illustrate how they can help to inform actuaries and payer coverage decisions through value assessment. There will be focus on what the value frameworks can help with today, and what questions still remain about the utility of the frameworks in the formulary decision making and health plan budgeting process. At the conclusion of this session, attendees will be able to: • Describe the purpose of the AMCP Dossier and the types of information included • Select relevant AMCP Dossier information for actuarial modeling • Describe the benefit of value frameworks to a health plan’s clinical and actuarial teams • Be familiar with how value frameworks like ICER could be used to augment the current formulary process. • Describe the challenges of using value frameworks for a health plan’s clinical and actuarial teams

Speakers

---

Presenters: Jim Davidson, PharmD, MBA: Karl Gregor, PharmD., MS, Kim Gwiazdzinski RPh, MBA, VP Value & Outcomes, Coeus Consulting Group
Moderator: Karl Gregor, PharmD., MS

1:00:00 PM - 2:15:00 PM ET - Prescription Drugs: Pricing, Trends, and Market Structure

View Session

Overview

---

This presentation provides a summary of how the prescription drug market is organized and priced, from the manufacturer to the patient and all the stakeholders inbetween. There will also be an overview of recent trend rates for prescription drugs and other changes in the prescription drug landscape such as rebates, coupons, specialty medications and biosimilars. At the conclusion of this session, attendees will be able to: • Describe the structure and key players in the pharmaceutical market • Understand the different pricing approaches used in different parts of the market • Compare drug pricing approaches and how they may impact their company or clients • Describe how recent trends in prescription drugs could affect future costs

Speakers

---

Presenters: Scott Fry, FSA, MAAA, Rebecca Owen, FSA, MAAA,FCA, Gregory Warren, FSA, MAAA, FCA
Moderator:

3:00:00 PM - 4:15:00 PM ET - Consumer Impact of the Prescription Drug Market

View Session

Overview

---

Pharmaceutical manufacturers use a variety of methods beyond simply targeting physicians to promote their products and gain market share. Direct-to-consumer advertising, drug manufacturer coupons, copay assistance programs, and drug rebates are strategies frequently employed to gain name recognition and address affordability concerns among consumers and gain access to a health plan's formulary. This session will explore the impact these strategies have had on consumers and their drug utilization patterns. In addition, it will highlight the government and health plans' responses to these strategies and why actuaries should be paying attention. At the conclusion of this session, attendees will be able to: • Understand the impact of direct-to-consumer advertising, drug manufacturer coupons, copay assistance programs and drug rebates on consumer behavior • Describe the government and health plans' responses to these strategies and potential impact • Explain why actuaries should be concerned with pharmaceutical manufacturers' methods for promoting their products

Speakers

---

Presenters: Johnathan Gray, ASA, CERA, Sarah Hellems, FSA, MAAA, CERA, Karen Nixon
Moderator:

11:00:00 AM - 12:15:00 PM ET - Medicare Advantage Benefit Innovations and the Challenge of Estimating ROI

View Session

Overview

---

The session will consist of an overview of benefit innovations in the Medicare Advantage program, including newly-permissible supplemental benefits, VBIDs and 'proximate flexibilities, such as rewards programs and provider network flexibilities that have the potential to impact member utilization and outcomes. The lead speaker is a former CMS leader and health plan product development VP who has spoken/written extensively on this topic. He will recruit two unconventional benefit vendors to speak regarding their benefit's potential to positively impact utilization and therefore partially offset the costs of their service. At the conclusion of this session, attendees will be able to: • Consider the full range of benefit/service flexibilities now available in the Medicare Advantage program • Understand how leading Medicare Advantage organizations are analyzing the likely positive impact of new benefits and services on their members and member utilization • Learn how actuaries can apply the likely utilization savings of new benefits and services to their bids and lead the analysis of benefits to determine actual savings

Speakers

---

Presenters: Michael Adelberg, Elizabeth Klodas, MD, FACC, Damian Rippole, Bill Alldredge
Moderator:

1:00:00 PM - 2:15:00 PM ET - Pathways to Success: Ride the Wave

View Session

Overview

---

In CMS's continued push toward value-based care, this session will discuss the evolution of the ACO program, specifically, the Pathways to Success (P2S) track. This will include a broad overview of the P2S program and CMS's goal to put more risk in the hands of providers. We will review some of the challenges faced by provider groups who are evaluating or currently participating in the program including the financial opportunities and risks. At the conclusion of this session, attendees will be able to: • Compare and contrast the ACO programs implemented by CMS in the advancement of value-based care • Identify key risks provider groups face when evaluating or participating in value-based care • Apply knowledge to evaluate the financial feasibility of participating in the P2S Program

Speakers

---

Presenters: David Byron, FSA, MAAA, Julie Witt, FSA
Moderator:

3:00:00 PM - 4:15:00 PM ET - Beyond the Bid: Monitoring Part D Financials from An In-house Actuary's Perspective

View Session

Overview

---

Many plan sponsors use external consulting actuaries to develop D Bids each June for the following year. After these bids, how should in-house actuaries monitor Part D experience over the next 18 months? During this session, the presenters will share their experiences in performing this role. First will be an overview of the common data sets available to plan sponsors and how they utilized them to develop special Part D reserves each month. After that, how to build a robust model to forecast Part D financials, including how to incorporate emerging experience, model monthly seasonalities and conduct meaningful scenario testing, will be covered.

Speakers

---

Presenters: Maxwell Hanna, ASA, MAAA, Kathryn Qin, FSA, MAAA
Moderator: Jackie Lee, FSA, MAAA

11:00:00 AM - 12:15:00 PM ET - Professionalism for the Medicaid Actuary

View Session

Overview

---

As Medicaid actuaries (consulting, MCO or state) we can experience daily challenges that test our professionalism and ethics. This session will present real-life situations in which Medicaid actuaries can find themselves and through online polling, allow the audience to help determine how to handle the situation and still obey the AAA Code of Professional Conduct. Panelists will also discuss each situation and provide their thoughts on appropriate professional behavior in each case. Attendees should leave with a better understanding of how to handle themselves in challenging ethical and professional situations within the guidelines published by the AAA in the Code of Professional Conduct.

Speakers

---

Presenters: Mark Blessinger, FSA, MAAA, Christina Mytelka, FSA, MAAA, Sudha Shenoy, FSA, MAAA, CERA, Stephanie Williams, FSA, MAAA
Moderator: Stephanie Williams, FSA, MAAA

1:00:00 PM - 2:15:00 PM ET - Medicaid - Oregon’s CCO 2.0

View Session

Overview

---

The Oregon Health Plan (Oregon's Medicaid Program) is being widely reformed in a process the state calls “CCO 2.0,” which is the second round of contracts for coordinated care organizations (CCOs), which deliver care to the vast majority of the state’s Medicaid members. In this session, the changes being made to rating structure, financial regulation regarding value-based care, social determinants of health and health-related services will be described. Many of these changes are way ahead of other states. The goals that Oregon is hoping to achieve will be described, along with how program changes will be implemented and tracked, and how these changes fit in with federal goals being set for Medicaid. How these changes are being delivered and received by the CCOs will be represented by three actuarial perspectives: the state, the consulting actuary for the state and an in-house CCO actuary. At the conclusion of this session, the attendees will be able to: • Describe recent changes to Oregon's Medicaid program. • Compare Oregon's Medicaid plan to their own state's Medicaid plan and be able to explain how Oregon’s changes help accomplish the triple aim.

Speakers

---

Presenters: Will Clark-Shim, FSA, MAAA, EA, Jessica Grado, Marilyn McGaffin, ASA, MAAA
Moderator:

3:00:00 PM - 4:15:00 PM ET - Impact of Behavioral Health Long Acting Injectables (LAIs) on Medicaid Member Cost

View Session

Overview

---

A multi-year study on how Behavioral Health Long Acting Injectables (LAIs) impact cost for adult Medicaid Members in multiple states. This session will discuss the changes in cost and utilization between Pharmacy, Medical and Behavioral Health services. Additionally, clinical benefits of LAIs and real life stories of how LAIs impact members will be discussed. At the conclusion of the session, attendees will be able to describe what a Long Acting Injectable (LAI) is, explain its intended use, evaluate potential cost and utilization impacts for adult Medicaid Members utilizing LAIs and describe member benefits when utilizing LAIs.

Speakers

---

Presenters: Rylan Austin, FSA, MAAA, Carole Maytas, VP, SMI Operations
Moderator:

11:00:00 AM - 12:15:00 PM ET - Lift Off! How Health Actuaries Are Using Non-Traditional Features and Advanced Methods to Increase Predictability

View Session

Overview

---

While algorithms like XGBoost and recurrent neural networks are all the rave, the backbone of predictive analytics and machine learning comes down to the right data and a strong foundation of engineering that data. In this presentation, actuaries and data scientists from the Cleveland Clinic and Milliman discuss novel data points and features that have provided increased predictability in models used across health care. This data ranges from publicly available information to patient-entered questionnaires, and includes social determinants of health, third-party consumer information, measures of functional and emotional status, and new twists on familiar concepts. The group will also discuss methods in feature engineering and their applications to real-world problem solving. Data and feature engineering are what really provide the lift in predicting outcomes. At the conclusion of this session, attendees will be able to: • Identify non-traditional data points to improve predictability • Understand various concepts regarding feature engineering • Explain how these two items help create better risk adjustment models

Speakers

---

Presenters: Joseph Dorocak, ASA, MAAA, Hans Leida, PhD., FSA, MAAA, Joe Long, Don McLellan, ASA, MAAA
Moderator:

1:00:00 PM - 2:15:00 PM ET - Hidden Bias - Identifying Unintended Consequences in Machine Learning

View Session

Overview

---

Over the past few years there have been several examples of machine learning models with unintended bias in applications ranging from hiring to provisioning healthcare services. As these models become more prevalent, identifying potential sources of bias and how to address them will become increasingly important. This session will cover some of the factors that can contribute to hidden bias as well as potential methods for identifying them. It will also address the role of actuarial subject matter expertise in combating potential issues. At the conclusion of the session, attendees will be able to: - Identify potential sources of bias in machine learning models - Evaluate a model for potential bias - Explain how actuaries can help combat potential bias in models

Speakers

---

Presenters:
Moderator:

3:00:00 PM - 4:15:00 PM ET - Frontiers of Machine Learning Models for Actuarial Applications

View Session

Overview

---

Artificial Intelligence and machine learning models have grown in both sophistication and complexity, and have demonstrated impressive accuracy and allowed deeper insights into claims, morbidity, customer stratification, and consumer behavior, to name a few. At the same time new techniques are being continuously developed, with ensemble learning methods replacing a single optimized model and new applications using Bayesian inference. To take advantage of this revolution in data, actuaries will need to understand both the theoretical underpinnings and practical applications of these models. We will briefly survey the landscape of models and explain how to construct and evaluate them, with an eye towards specific applications like group morbidity projection. We will also demonstrate concrete examples for how and why some fundamental models can be used to model uncertain quantities in health insurance in ways that improve on traditional actuarial predictions. Finally we will look at the frontier of advanced analytics and survey cutting edge techniques such as Bayesian Additive Regression Trees that may be implemented in the future to improve actuarial practice. Understand theoretical motivation and concrete application of latest machine learning models, and how and when to apply them.

Speakers

---

Presenters:
Moderator:

11:00:00 AM - 12:15:00 PM ET - What Are We Trying to Prevent Anyways? Considerations When Re-thinking the Preventive Services Definition

View Session

Overview

---

The introduction of the Patient Protection and Affordable Care Act (ACA) brought about many legislative changes intended to improve the health of people in all healthcare markets (ACA, Medicare, Medicaid, Employer) in the United States. One such changes was the introduction of mandatory zero cost coverage for services determined to be "preventive"based on clinical criteria. In this session, we explore the evolution and scope expansion of the preventive category and other considerations, including historical utilization and cost of existing preventive services, before contemplating possible future changes to the ACA preventive list. This session is targeted towards actuaries working for health plans or state or federal regulatory agencies interested in learning about how the ACA preventive list could be modified to improve the long-term health of populations.

Speakers

---

Presenters: Barbara Collier, FSA, MAAA, Michelle Klein, FSA, MAAA
Moderator: Dave Dillion, FSA, MAAA

1:00:00 PM - 2:15:00 PM ET - Best Practices for ACA Rate Filings

View Session

Overview

---

This session will feature a panel of health actuaries with intimate knowledge of the ACA rate filing process. Each panelist will deliver a short presentation focused on best practices for specific aspects of the ACA rate filing process including rate development, the creation of rate filing justification documents including actuarial memoranda, responding to rate review objections, compliance with the relevant ASOPs, professionalism and communication. The panel will include health actuaries who provide rate review services for state departments of insurance, health actuaries who provide rate review services for health plans, and health actuaries who develop ACA rates and file ACA rate filing justification documents. Each panelist will present for five to ten minutes, and then the floor will be opened up for questions from the audience and discussion.

Speakers

---

Presenters: Dave Dillon, FSA, MAAA. Lewis and Ellis, Annette James, FSA, MAAA. NovaRest Blue Cross/Blue Shield of Illinois, Steven Kesten FSA,MAAA, Joseph P Slater FSA,MAAA
Moderator:

3:00:00 PM - 4:15:00 PM ET - The Role of the Actuary in the ACA's 2nd Decade

View Session

Overview

---

Traditionally, Americans have received health benefit coverage through two distinct and separate platforms: private insurance and government programs (primarily Medicare and Medicaid). Private insurance has been invited to participate in government programs, but the government remains the primary payer of insurance premiums. The ACA blended these platforms with markets that are supported by premiums that are paid by various combinations of personal funds and government subsidies. Market enrollment is lower than anticipated and ongoing challenges are actuarial in nature, particularly with regard to ASOP 12 consideration of risk classification. As we continue to pivot from original ACA design, proposed solutions will require actuarial thought. This roundtable discussion will explore how actuaries can contribute to sound financial policy.

Speakers

---

Presenters: Daniel Cruz, ASA, MAAA, Gregory Fann, FSA,MAAA,FCA, Stan Dorn
Moderator:

11:00:00 AM - 12:15:00 PM ET - The Case for Individual Disability Insurance

View Session

Overview

---

Individual Disability Insurance (IDI) is a complex and specialized product, but it is an important source of income replacement for people who do not have access to group disability insurance, or for whom group coverage does not provide adequate coverage. Although the IDI market experience financial challenges and consolidation in the 1990s, it has been a profitable business for many years. This session explores the IDI market form the varying perspective of insurance carriers, brokers, and customers. It explores product design, risk issues, and market trends to make the case that the product remains both important and financially viable.

Speakers

---

Presenters: Daniel Wisted
Presenter/Moderator: Daniel D Skwire FSA,MAAA

1:00:00 PM - 2:15:00 PM ET - Trends in Paid Family and Medical Leave Coverage

View Session

Overview

---

Paid family and medical leave coverage represents one of the most rapidly growing segments of the group disability business. The design and management of these programs is a unique intersection of public and private insurance programs, and it poses a number of challenges and opportunities for insurance carriers. Plan design and pricing can be a challenges for this new type of coverage, with only modest amounts of experience data available, and this can be further complicated by state laws and regulations that mandate benefit provisions or even the level of premium rates. In addition, companies offering these benefits must design systems and staffing solutions to support a coverage that differs in important ways from existing short term disability plans. The speakers in this session provide an overview and update on recent activity in the paid family and medical leave space, along with sharing their thoughts on keys to success and potential pitfalls.

Speakers

---

Presenters: Paul Luis Correia FSA,CERA,MAAA,Brian N Dunham FSA,MAAA, Matthew Ryan Desfosses ASA,MAAA
Moderator: 

3:00:00 PM - 4:15:00 PM ET - COVID-19 and other Mortality and Morbidity Trends in Group Life and Group Disability

View Session

Overview

---

The session will address recent trends in Group Life and Group Disability mortality/morbidity, including information regarding COVID-19 impacts.  The presenters will drill into specific segments and discuss what makes them different.  The presenters will draw from information gathered from SOA studies, the CDC and other government agencies, as well as other proprietary research.  Attendees will leave the session better informed about Group Life and Disability mortality and morbidity trends and forecasting, including the impact of COVID-19.

Speakers

---

Presenters: Richard Leavitt, ASA, MAAA & Stephen J Rulis FSA,MAAA
Moderator: Daniel D Skwire FSA,MAAA

11:00:00 AM - 12:15:00 PM ET - Applying Social Determinants of Health Analytics to Drive Clinical, Operational and Financial Performance

View Session

Overview

---

60 percent to 80 percent of health care costs are attributed a member’s lifestyle choices, needs and wants, yet the healthcare industry has historically relied primarily on clinical and claims data for analytics. Integrating social determinants of health analytics into health care operations is enabling significant insights and measurable improvement across a multitude of payer functions, including many actuarial areas like evaluation of distribution channels, plan design, pricing, experience analysis, and risk assessment and adjustment. Learn how payers are now gaining new understandings across all lines of business to gain competitive advantages. Attendees will learn: • The types of data used to predict social determinants of health for an individual • Specific applications of how actuaries and data scientists are applying social determinants of health to drive improved performance and some illustrative results • The actuarial profession is in the early stages of leveraging this information and much more can be accomplished through greater awareness

Speakers

---

Presenters: James Dolstad, ASA, MAAA, Jonathan Schleder, Dominique Altieri, Seth Serxner, Stoddard Davenport
Moderator:

1:00:00 PM - 2:15:00 PM ET - Leveraging Social Determinants of Health Analytics to Improve Clinical Performance

View Session

Overview

---

As providers take on more and more risk they need to understand their patients more holistically as the majority of healthcare costs are the result of an individual's lifestyle choices, needs and wants. By understanding their patient's lifestyle, environment, needs and wants, through the integration of social determinants of health analytics, providers can work smarter and accelerate their success as they transform to value based care. At the conclusion of this session, attendees will learn: • The data sources used for social determinant of health analytics • Descriptive and predictive analytics use cases to support value based care • How to start using social determinant analytics, and expand the use over time

Speakers

---

Presenters: Kevin Dotson, FSA, MAAA, Patrick M Curran FSA,MAAA, Robert Jason Reed FSA,MAAA, Robert Joseph Nation ASA,MAAA
Moderator:

3:00:00 PM - 4:15:00 PM ET - Using Alternative Measures of Social Determinants of Health to Assess Population Risk

View Session

Overview

---

Social Determinants of Health (SDOH) include the social and physical conditions in which people are born, live and work on a daily basis. These factors account for 50 percent of the modifiable contributors to health outcomes and include education, job status, income, social support, safety and the physical environment. The overall aim of this session is to show how well different measures of SDOH quantify and characterize patient risk status in order to optimize a variety of population health and payment purposes. These researchers will evaluate SDOH data from publicly available census data, individual-level information gathered from direct patient screening, as well as hybrid models. At the conclusion of this session, attendees will be able to: • Determine different ways of gathering SDOH data and incorporating it to stratify risk of patients • Develop strategies to address some of these social determinants with the goal of improving health and cost outcomes

Speakers

---

Presenters: Rachel Everhart, PhD, Shelly Moss, ASA, MAAA, Tracy Johnson
Moderator: Jill Van Den Bos, ASA, MAAA

12:00 PM - 1:30 PM ET - Women’s Leadership Forum (and Men Come, too)

View Session

Overview

---

Leadership Lessons in the Age of COVID-19: Branding, Networking, and Storytelling All genders are welcome to learn and practice “must have” skills to propel your business presence and impact. The spotlight on communication skills and relationship building have never been greater than in this virtual moment. Join us as we build a practical tool kit. This session is co-sponsored by the SOA 2020 Virtual Health Meeting and WING (Women’s Insurance Networking Group).

Speakers

---

Presenters: Coming Soon Moderator: